SEC Form 4 · accession 0001193125-26-363737
TREACE MEDICAL CONCEPTS, INC. · TMCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T. Treace
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Aug 20, 2026
Accepted (ET)
Aug 24, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001630627
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 20, 2026 | P | 39,944 | $4.4356 | A | 7,388,383 | D | |
| Common StockF2 | Aug 21, 2026 | P | 5,000 | $4.3495 | A | 7,393,383 | D | |
| Common StockF3,F2 | Aug 24, 2026 | P | 11,000 | $4.3392 | A | 7,404,383 | D | |
| Common StockF4 | holding | — | — | — | 1,605,000 | I | By spouse | |
| Common StockF4 | holding | — | — | — | 1,471,250 | I | By spouse as trustee of a trust | |
| Common StockF5 | holding | — | — | — | 1,839,063 | I | As trustee of a trust | |
| Common StockF5 | holding | — | — | — | 408,816 | I | As co-trustee of a trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3198 to $4.5048 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F2Includes 542,784 restricted stock units.
- F3The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3097 to $4.3489 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F4The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
- F5The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.